TORNTPHARM — Torrent Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹866.35bn
- IN₹901.80bn
- IN₹96.20bn
- 96
- 11
- 98
- 83
2019 March 31st | R2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 5,617 | 11,866 | 15,263 | 12,259 | 18,472 |
Depreciation | |||||
Non-Cash Items | 8,005 | 2,218 | 3,351 | 6,878 | 2,307 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,818 | -6,699 | -5,138 | -7,729 | -3,574 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 17,981 | 13,929 | 20,054 | 18,030 | 24,270 |
Capital Expenditures | -6,628 | -4,068 | -3,352 | -2,026 | -5,739 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 4,216 | 6,054 | -1,143 | 59.4 | -18,414 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,413 | 1,986 | -4,494 | -1,966 | -24,153 |
Financing Cash Flow Items | -5,034 | -4,854 | -3,561 | -2,577 | -3,030 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -13,145 | -15,490 | -16,508 | -17,811 | 774 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2,380 | 731 | -893 | -1,742 | 1,101 |